Consistent reporting of lab incidents is not only required as part of the NIH guidelines and University of Minnesota policies. It’s also a critical part of the overall research process.

The Using Controlled Substances for Research policy is currently under review. Therefore, the requirement for Minnesota Board of Pharmacy registrations will be delayed until further notice.

The Institutional Review Board is engaging in collaborative agreements with other institutions to streamline reviews and avoid duplication.

Following a consultative review process, the University of Minnesota’s fixed price contracts policy has been updated and posted online.